Heparin-Induced Thrombocytopenia: Symptoms, Causes, Treatment

Not every platelet fall during heparin treatment is HIT. Other causes are common, so clinicians estimate the probability before testing or changing anticoagulation.

Related reading: A different disorder involving platelet counts.

A substantial platelet fall may be the first sign. Painful leg swelling, breathlessness, chest pain, injection-site skin changes or clots elsewhere may develop.

Antibodies against heparin–platelet factor 4 complexes activate platelets and clotting. Onset is commonly several days after exposure, sometimes sooner following recent previous heparin use.

Heparin exposure is essential context. Unfractionated heparin and some surgical settings carry higher risk; HIT is less common with low-molecular-weight heparin.

A clinical score considers the size and timing of the fall, thrombosis and alternative causes. Antibody and sometimes functional testing follows; a positive antibody result alone is insufficient.

With meaningful clinical suspicion, the team stops all heparin sources and selects a non-heparin anticoagulant. Stopping alone is often insufficient; warfarin should not start before platelet recovery.

Pulmonary embolism, stroke or impaired limb and organ blood supply may occur. Treatment balances clotting and bleeding risks; anticoagulation duration depends on the confirmed diagnosis.

Tell every care team about confirmed previous HIT and keep a medication-reaction record. Do not stop anticoagulation yourself; alternatives and platelet monitoring require clinical oversight.